489 related articles for article (PubMed ID: 17881023)
21. Changes in presentation and survival of head and neck carcinomas in Northeastern Italy, 1975-1998.
Barzan L; Talamini R; Franchin G; Vaccher E; Politi D; Minatel E; Gobitti C
Cancer; 2002 Aug; 95(3):540-52. PubMed ID: 12209746
[TBL] [Abstract][Full Text] [Related]
22. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
[TBL] [Abstract][Full Text] [Related]
23. [Mouth floor and mobile tongue epidermoid carcinomas thickness: prognostic value].
El-Okeily M; El-Bouihi M; Ricard AS; Lefebvre-Majoufre C; Deminière C; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2008 Apr; 109(2):81-5. PubMed ID: 18328517
[TBL] [Abstract][Full Text] [Related]
24. Second salvage surgery for re-recurrent oral cavity and oropharynx carcinoma.
Agra IM; Filho JG; Martins EP; Kowalski LP
Head Neck; 2010 Aug; 32(8):997-1002. PubMed ID: 20191624
[TBL] [Abstract][Full Text] [Related]
25. [Multiple carcinomas in the upper aerodigestive tract. 1. Oral cavity and oropharynx].
Popella C; Bödeker R; Glanz H; Köhl S
Laryngorhinootologie; 1999 Dec; 78(12):671-8. PubMed ID: 10666693
[TBL] [Abstract][Full Text] [Related]
26. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
[TBL] [Abstract][Full Text] [Related]
27. Alcohol dehydrogenase 3 genotype as a risk factor for upper aerodigestive tract cancers.
Nishimoto IN; Pinheiro NA; Rogatto SR; Carvalho AL; de Moura RP; Caballero OL; Simpson A; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):78-82. PubMed ID: 14732773
[TBL] [Abstract][Full Text] [Related]
28. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
Rosenquist K; Wennerberg J; Annertz K; Schildt EB; Hansson BG; Bladström A; Andersson G
Acta Otolaryngol; 2007 Sep; 127(9):980-7. PubMed ID: 17712679
[TBL] [Abstract][Full Text] [Related]
29. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients.
González-García R; Naval-Gías L; Román-Romero L; Sastre-Pérez J; Rodríguez-Campo FJ
Head Neck; 2009 Sep; 31(9):1168-80. PubMed ID: 19408289
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the oral cavity, pharynx, and larynx in young adults.
Lipkin A; Miller RH; Woodson GE
Laryngoscope; 1985 Jul; 95(7 Pt 1):790-3. PubMed ID: 4010418
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
32. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
Ozer E; Grecula JC; Agrawal A; Rhoades CA; Young DC; Schuller DE
Laryngoscope; 2006 Apr; 116(4):607-12. PubMed ID: 16585867
[TBL] [Abstract][Full Text] [Related]
33. Analysis of death certification in patients with early stage oral cavity squamous cell carcinoma.
Kademani D; Baltali E; Lewis J; Keller E
J Oral Maxillofac Surg; 2007 Jun; 65(6):1191-7. PubMed ID: 17517305
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic influence of cutaneous involvement in malignant tumors of the oral cavity].
Tankéré F; Camproux A; Barry B; Guedon C; Depondt J; Gehanno P
Ann Otolaryngol Chir Cervicofac; 2000 Mar; 117(2):85-90. PubMed ID: 10739997
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
36. [Value of panendoscopy in assessment of mouth cavity, pharyngeal and laryngeal cancers].
Stöckli SJ; Zimmermann R
Schweiz Med Wochenschr Suppl; 2000; 116():15S-17S. PubMed ID: 10780063
[TBL] [Abstract][Full Text] [Related]
37. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
[TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
Mosleh-Shirazi MS; Mohammadianpanah M; Mosleh-Shirazi MA
J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx.
Moncrieff M; Sandilla J; Clark J; Clifford A; Shannon K; Gao K; O'Brien C
Laryngoscope; 2009 Feb; 119(2):307-11. PubMed ID: 19172611
[TBL] [Abstract][Full Text] [Related]
40. [Distant metastasis and incidence of second carcinomas in patients with oropharyngeal and hypopharyngeal carcinomas].
Mohadjer C; Dietz A; Maier H; Weidauer H
HNO; 1996 Mar; 44(3):134-9. PubMed ID: 8641899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
